Long-term outcome of infective endocarditis in non-intravenous drug users

Mayo Clinic Proceedings

Volumn 83, Issue 11, 2008, Pages 1213-1217

  Martínez Sellés, Manuel ^a   Muñoz, Patricia ^a   Estevez, Alvaro ^a   Del Castillo, Roberto ^a   García Fernández, Miguel Angel ^a   Rodríguez Créixems, Marta ^a   Moreno, Mar ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; DRUG ABUSE; FEMALE; FOLLOW UP; HEART VALVE; HEART VALVE PROSTHESIS; HOSPITAL DISCHARGE; HUMAN; INTRAVENOUS DRUG ABUSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; NON INTRAVENOUS DRUG ABUSE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RECURRENT INFECTION; SURGICAL MORTALITY; SURVIVAL RATE;

EID: 55549131564     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.11.1213     Document Type: Article

References (25)

1. Bouza E, Menasalvas A, Muñoz P, Vasallo FJ, del Mar Moreno M, García Fernández MA. Infective endocarditis - a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80(5):298-307.
2. Hoen B. Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart. 2006;92(11):1694-1700. doi:10.1136/hrt.2005.072595.
3. Hoen B, Alla F, Selton-Suty C, et al; Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75-81. doi:10.1001/jama.288.1.75.
4. Tornos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts: a 15-year follow-up study. Ann Intern Med. 1992;117(7):567-572.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-383.
6. Durack DT, Lukes AS, Bright DK; Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96(3):200-209. doi:10.1016/0002-9343(94)90143-0.
7. Miró JM, Moreno A, Mestres CA. Infective endocarditis in intravenous drug abusers. Curr Infect Dis Rep. 2003;5(4):307-316.
8. Heiro M, Helenius H, Mäkilä S, et al. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart. 2006 Oct;92(10):1457-1462. Epub 2006 Apr 27. doi:10.1136/hrt.2005. 084715.
9. Nissen H, Nielsen PF, Frederiksen M, Helleberg C, Nielsen JS. Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. Eur Heart J. 1992;13(7):872-877.
10. Anguita Sánchez M, Torres Calvo F, Castillo Domínguez JC, et al. Short- and long-term prognosis of infective endocarditis in non-injection drug users: improved results over 15 years (1987-2001) [in Spanish]. Rev Esp Cardiol. 2005;58(10):1188-1196.
11. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(1):90-94.
12. Fowler VG Jr, Miro JM, Hoen B, et al; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress [published correction appears in JAMA. 2005;294(8):900]. JAMA. 2005;293(24):3012-3021. doi:10.1001/jama.293.24.3012.
13. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91(5):571-575.
14. Ferreiros E, Nacinovich F, Casabé JH, et al; EIRA-2 Investigators. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina-2 (EIRA-2) Study. Am Heart J. 2006;151(2):545-552. doi:10.1016/j.ahj.2005.04.008.
15. Loupa C, Mavroidi N, Boutsikakis I, et al. Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect. 2004;10(6):556-561. doi:10.1111/j.1469-0691. 2004.00884.x.
16. Castillo JC, Anguita MP, Ramirez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart. 2000;83(5):525-530. doi.10.1136/heart.83.5.525.
17. San Román JA, López J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120(4):369.e1-e7. doi:10.1016/j.amjmed.2006.05.071.
18. Tran CT, Kjeldsen K. Endocarditis at a tertiary hospital: reduced acute mortality but poor long term prognosis. Scand J Infect Dis. 2006;38(8):664-670. doi:10.1080/00365540600585180.
19. Malquarti V, Saradarian W, Etienne J, Milon H, Delahaye JP. Prognosis of native valve infective endocarditis: a review of 253 cases. Eur Heart J. 1984;5(suppl C):11-20.
20. Vlessis AA, Hovaguimian H, Jaggers J, Ahmad A, Starr A. Infective endocarditis: ten-year review of medical and surgical therapy. Ann Thorac Surg. 1996;61(4):1217-1222. doi:10.1016/0003-4975(96)00029-X.
21. Olaison L, Hogevik H, Myken P, Oden A, Alestig K. Early surgery in infective endocarditis. QJM. 1996;89(4):267-278.
22. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg. 1986;92(4):776-783.
23. Wang A, Athan E, Pappas PA, et al; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354-1361.
24. Mansur AJ, Dal Bó CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J. 2001;141(1):78-86. doi:10.1067/mhj.2001.111952.
25. Netzer RO, Altwegg SC, Zollinger E, Täuber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002;88(1):61-66. doi:10.1136/heart.88.1.61.